CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy

Overview of attention for article published in Journal of Neuro-Oncology, August 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

UCSD Neurosurgery, 01 Sep 2012

New Publication from the CTAN Lab! on the power of combining anti-angiogenic therapy with radiation and chemotherapy for the…